echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Alzheimers Dementia: New discovery of neurofilament light chain: Differentiate between mental illness and dementia

    Alzheimers Dementia: New discovery of neurofilament light chain: Differentiate between mental illness and dementia

    • Last Update: 2022-03-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Despite significant advances in clinical neuroscience, many patients with cognitive and neuropsychiatric symptoms still face years of multiple evaluations, diagnostic uncertainty and delays, misdiagnosis, and imprecise management and prognosis in a major diagnostic odyssey, There are significant negative impacts on patients, families and the healthcare system


    Behavioral variant frontotemporal dementia (bvFTD) and Alzheimer's disease (AD) are clinically diagnosed with significant error rates


    A biomarker that can help differentiate neurodegenerative and psychiatric disorders will have a major impact on patient care and assessment, as well as outcomes



    Therefore, dDhamidhu Eratn et al.


    This study, part of the Neuropsychiatric Disorders Study (MiND Study), was designed to expand on our earlier pilot work in a large, diverse cohort presenting with cognitive and neuropsychiatric symptoms, where the differential diagnosis included psychosis and neurological/neurodegeneration sexually transmitted diseases


    Secondary objectives included assessing the diagnostic utility of NfL and t-tau in differentiating ND, PSY, CJD/RapidND groups, and specific diagnoses within these groups


    They found that NfL was elevated in ND compared with PSY and controls, with the highest levels in CJD and RapidND


    Compared with PSY and controls, NfL was elevated in ND, with the highest levels in CJD and RapidND


    The significance of this study is that it demonstrates that the diagnostic utility of CSF NfL in differentiating ND from psychiatric disorders has strong generalizability and high accuracy


    Diagnostic utility of CSF NfL in distinguishing ND from psychiatric disorders with strong generalizability

     








    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.